Filing Flows › Longeveron (LGVN) › R&D spending
Longeveron (LGVN) R&D spending by quarter
Longeveron's R&D spending was $3.2M in Q2 2026 (second quarter 2026), +38% from Q1 2026. Over the last 7 quarters it ranged from $2.0M (Q4 2024) to $3.9M (Q3 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $3.2M | +38% | +8% |
| Q1 2026 | $2.3M | -15% | -8% |
| Q4 2025 | $2.7M | -29% | +37% |
| Q3 2025 | $3.9M | +30% | — |
| Q2 2025 | $3.0M | +17% | — |
| Q1 2025 | $2.5M | +26% | — |
| Q4 2024 | $2.0M | — | — |
Q2 2026 at a glance
Longeveron, Q2 2026: revenue $287K (-9% year over year), net loss $6.1M, operating cash flow −$5.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Longeveron's R&D spending?
Longeveron's R&D spending was $3.2M in Q2 2026 (second quarter 2026), +38% from Q1 2026.
How has Longeveron's R&D spending changed?
Over the last 7 quarters it ranged from $2.0M (Q4 2024) to $3.9M (Q3 2025).